Clinical Trials Directory

Trials / Terminated

TerminatedNCT02257775

Evolution of Resistance to Systemic Therapies in Patients With Breast Cancer

Status
Terminated
Phase
Study type
Observational
Enrollment
5 (actual)
Sponsor
Institute of Cancer Research, United Kingdom · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to apply Whole-body DW imaging alongside the routine management of patients requiring systemic therapy for metastatic breast cancer to compare the time to progression of individual liver metastases within and between patients following stable disease or partial response to palliative systemic therapy for breast cancer.

Conditions

Interventions

TypeNameDescription
GENETICn/a - observational

Timeline

Start date
2015-05-11
Primary completion
2017-11-23
Completion
2017-11-23
First posted
2014-10-06
Last updated
2018-01-30

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT02257775. Inclusion in this directory is not an endorsement.